Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic ...
In honor of Charley Steven Myers, the Success Bell was created for all MCES students to ring when they accomplish success.
Acute lymphoblastic leukemia (ALL) is a type of cancer that primarily affects children, although it can also occur in adults. Recent research has focused on understanding the genetic factors that ...
Much has been achieved in terms of understanding the complex clinical and genetic heterogeneity of Charcot-Marie-Tooth neuropathy (CMT). Since the identification of mutations in the first CMT ...
A population-based study indicates that among children with cancer, those with obesity at the time of diagnosis may face an elevated risk of dying. The findings are published online in Cancer. A ...
Your child might have a stem cell transplant as part of their treatment for acute lymphoblastic leukaemia (ALL). Having a transplant means destroying as many leukaemia cells as possible and replacing ...
Research has shown that we need to give different treatment to babies that are under 1 year old when they are diagnosed. This information is for children over 1. Your hospital consultant can give you ...
Objective: Non-alcoholic steatohepatitis (NASH) is a progressive liver disease with lipid accumulation, inflammation, and liver fibrosis. Ponatinib, a third-generation tyrosine kinase inhibitors for ...
Essen Biotech is a research center that offers natural killer cell immuno, MSC stem, bone marrow transplant, proton therapy and CAR-T cell therapy services for the treatment of Alzheimer’s disease, ...
AZD-0486 is under clinical development by AstraZeneca and currently in Phase II for B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia). According to GlobalData, Phase II drugs ...
With the identification of the mutation responsible for most FD cases, carrier testing began. Carrier testing, based on DNA analyses, is available for the two most common mutations (major haplotype ...